Suppr超能文献

饮用水中溴二氯甲烷对雄性F344/N大鼠和B6C3F1小鼠的致癌性。

Carcinogenicity of bromodichloromethane administered in drinking water to Male F344/N Rats and B6C3F1 mice.

作者信息

George Michael H, Olson Greg R, Doerfler Donald, Moore Tanya, Kilburn Steve, DeAngelo Anthony B

机构信息

National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.

出版信息

Int J Toxicol. 2002 May-Jun;21(3):219-30. doi: 10.1080/10915810290096351.

Abstract

A life-time exposure study was conducted to assess the carcinogenicity of bromodichloromethane (BDCM) administered in the drinking water to male F344/N rats and B6C3F(1) mice. In mouse, the calculated mean daily BDCM concentrations (measured concentrations corrected for on-cage loss of chemical) were 0.06, 0.28 and 0.49 g/l. Time-weighted water consumption of 135, 97, and 89 ml/kg/day resulted in mean daily doses of 8.1, 27.2, and 43.4 mg BDCM/kg/day. No changes in feed consumption, final body weight, or survival were observed. Kidney weights were significantly depressed at 27.2 and 43.4 mg BDCM/kg/day. There was no increase in neoplasia in the liver, kidney, spleen, testis, bladder, sections along the alimentary tract, excised lesions, or at any other organ site. In rat, the corrected mean daily BDCM concentrations were 0.06, 0.33, and 0.62 g/l. Time-weighted water consumption of 65, 63, and 59 ml/kg/day yielded 3.9, 20.6 and 36.3 mg BDCM/kg/day. No alterations in feed consumption, body weight gain, and survival were seen. Kidney weight was significantly depressed in the 36.3-mg/kg/day treatment group. There was a significantly enhanced prevalence and multiplicity of hepatocellular adenomas at 3.9 mg BDCM/kg/day (15.5% and 0.16/animal vs. 2.2% and 0.02/animal for the control). Hepatocellular carcinomas increased from 2.2% and 0.02/animal for the control and 3.9 mg BDCM/kg/day to 8.3% and 0.10/animal at 20.6 mg BDCM/kg/day. The combined neoplasms were enhanced at 3.9 and 20.6 mg BDCM/kg/day. Liver neoplasia was depressed to the control value at 36.3 mg BDCM/kg. The prevalence of basophilic and clear cell, but not eosinophilic cells, altered foci of cells declined with increasing dose. BDCM did not increase cancer in the large bowel, renal tubules, or in any of the other tissues examined. Renal tubular hyperplasia was observed at 36.3 mg BDCM/kg (15.8% vs. 8.7% for the control group). Under the conditions of the study, BDCM in the drinking water was not carcinogenic in the male B6C3F(1) mouse, but was carcinogenic in the male F344/N rat based on an increased hepatocellular neoplasia.

摘要

进行了一项终生暴露研究,以评估饮用水中给予雄性F344/N大鼠和B6C3F(1)小鼠的溴二氯甲烷(BDCM)的致癌性。在小鼠中,计算得出的BDCM平均每日浓度(经笼内化学物质损失校正后的测量浓度)分别为0.06、0.28和0.49 g/l。时间加权饮水量分别为135、97和89 ml/kg/天,导致BDCM的平均每日剂量分别为8.1、27.2和43.4 mg/kg/天。未观察到饲料消耗、终末体重或存活率的变化。在BDCM剂量为27.2和43.4 mg/kg/天时,肾脏重量显著降低。在肝脏、肾脏、脾脏、睾丸、膀胱、消化道各段、切除的病变或任何其他器官部位,肿瘤形成均未增加。在大鼠中,校正后的BDCM平均每日浓度分别为0.06、0.33和0.62 g/l。时间加权饮水量分别为65、63和59 ml/kg/天,产生的BDCM剂量分别为3.9、20.6和36.3 mg/kg/天。未观察到饲料消耗、体重增加和存活率的改变。在36.3 mg/kg/天的治疗组中肾脏重量显著降低。在BDCM剂量为3.9 mg/kg/天时,肝细胞腺瘤的发生率和多发性显著增加(分别为15.5%和0.16/动物,而对照组为2.2%和0.02/动物)。肝细胞癌从对照组和3.9 mg/kg/天的2.2%和0.02/动物增加到20.6 mg/kg/天时的8.3%和0.10/动物。在BDCM剂量为3.9和20.6 mg/kg/天时,合并肿瘤增加。在36.3 mg/kg时肝脏肿瘤形成降至对照值。嗜碱性和透明细胞(而非嗜酸性细胞)改变的细胞灶的发生率随剂量增加而下降。BDCM未增加大肠、肾小管或任何其他检查组织中的癌症发生率。在BDCM剂量为36.3 mg/kg时观察到肾小管增生(15.8%,而对照组为8.7%)。在本研究条件下,饮用水中的BDCM对雄性B6C3F(1)小鼠无致癌性,但基于肝细胞肿瘤形成增加,对雄性F344/N大鼠有致癌性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验